Mohammed M Aboelsoud1, Amen I Javaid2, Mazen O Al-Qadi3, James H Lewis4. 1. Department of Medicine, Memorial Hospital of Rhode Island/Alpert Medical School of Brown University, 11l1 Brewster St, Pawtucket, RI 02860, USA. Electronic address: Mohammed_Aboelsoud@brown.edu. 2. Department of Medicine, Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007, USA. Electronic address: Amenismail88@gmail.com. 3. Department of Medicine, Yale-New Haven Hospital, 20 York St, New Haven, CT 06510, USA. Electronic address: Mazen.al-qadi@ynhh.org. 4. Division of Gastroenterology and Hepatology, Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007, USA. Electronic address: Lewisjh@gunet.georgetown.edu.
Abstract
PURPOSE: A retrospective analysis of critically-ill patients with hypoxic hepatitis (HH) to characterize the biochemical profile and to identify predictors of mortality using the Medical Information Mart for Intensive Care III database. METHODS: HH was defined as a rapid increase in AST/ALT≥800IU/L after exclusion of other causes. We investigated the correlation between various clinical and laboratory parameters and mortality rates using regression models. RESULTS: Among 38,645 ICU-patients, 565 (1.46%) were diagnosed with HH; 57.9% were males; median age was 63years. The unique biochemical profile of HH was confirmed; lactate dehydrogenase (LDH) was higher than both ALT and AST; AST>ALT for the first 2days then the ratio is reversed until recovery. All-cause hospital mortality was 44.1%. All-cause hospital mortality was 44.1%. On multivariate analysis, older age, higher SAPS-II, higher INR, higher bilirubin, higher LDH, acute kidney injury (AKI), and the need for vasopressors were independently associated with mortality. CONCLUSION: Older age, higher SAPS-II, LDH, INR and bilirubin levels, concomitant AKI and the need for vasopressors were all factors associated with increased mortality. The diagnosis of HH was an important harbinger of mortality in this population, which appears to be driven mainly by the severity of the underlying conditions.
PURPOSE: A retrospective analysis of critically-illpatients with hypoxic hepatitis (HH) to characterize the biochemical profile and to identify predictors of mortality using the Medical Information Mart for Intensive Care III database. METHODS: HH was defined as a rapid increase in AST/ALT≥800IU/L after exclusion of other causes. We investigated the correlation between various clinical and laboratory parameters and mortality rates using regression models. RESULTS: Among 38,645 ICU-patients, 565 (1.46%) were diagnosed with HH; 57.9% were males; median age was 63years. The unique biochemical profile of HH was confirmed; lactate dehydrogenase (LDH) was higher than both ALT and AST; AST>ALT for the first 2days then the ratio is reversed until recovery. All-cause hospital mortality was 44.1%. All-cause hospital mortality was 44.1%. On multivariate analysis, older age, higher SAPS-II, higher INR, higher bilirubin, higher LDH, acute kidney injury (AKI), and the need for vasopressors were independently associated with mortality. CONCLUSION: Older age, higher SAPS-II, LDH, INR and bilirubin levels, concomitant AKI and the need for vasopressors were all factors associated with increased mortality. The diagnosis of HH was an important harbinger of mortality in this population, which appears to be driven mainly by the severity of the underlying conditions.
Authors: M Diab; C Sponholz; C von Loeffelholz; P Scheffel; M Bauer; A Kortgen; T Lehmann; G Färber; M W Pletz; T Doenst Journal: Infection Date: 2017-08-30 Impact factor: 3.553
Authors: Astrid Van den Broecke; Laura Van Coile; Alexander Decruyenaere; Kirsten Colpaert; Dominique Benoit; Hans Van Vlierberghe; Johan Decruyenaere Journal: Ann Intensive Care Date: 2018-01-30 Impact factor: 6.925
Authors: Yun Im Lee; Min Goo Kang; Ryoung-Eun Ko; Taek Kyu Park; Chi Ryang Chung; Yang Hyun Cho; Kyeongman Jeon; Gee Young Suh; Jeong Hoon Yang Journal: J Clin Med Date: 2020-09-16 Impact factor: 4.241
Authors: José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega Journal: Int J Mol Sci Date: 2020-12-10 Impact factor: 5.923
Authors: Mohammed Ewid; Hossam Sherif; Abdulaziz S Allihimy; Shaima A Alharbi; Dawood A Aldrewesh; Sarah A Alkuraydis; Rami Abazid Journal: BMC Res Notes Date: 2020-03-24
Authors: Csaba Eke; András Szabó; Ádám Nagy; Boglár Párkányi; Miklós D Kertai; Levente Fazekas; Attila Kovács; Bálint Lakatos; István Hartyánszky; János Gál; Béla Merkely; Andrea Székely Journal: Diagnostics (Basel) Date: 2022-03-12